Richter Transformation Lymphoma Completed Phase 1 Trials for Zilovertamab vedotin (DB18457)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0117440 (Richter Transformation Lymphoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03833180 | A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) | Treatment |